ArticleJournal of gastrointestinal oncology2026
No survival benefit from adjuvant chemotherapy in high-risk stage II small intestinal adenocarcinoma after surgery: a population-based long-term survival analysis.
Zhigang Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.